What we do
Founded in 2013, the International Hypoglycaemia Study Group (IHSG) grew out of a need to address the challenge of hypoglycaemia in diabetes. Despite significant advances in the medical treatment of diabetes, hypoglycaemia continues to pose a serious problem for many patients and to place limits on glycaemic control. In addition to advancing the scientific understanding of hypoglycaemia, the IHSG seeks to create and disseminate solutions that will improve patients’ lives.
The IHSG’s overarching goal is to improve the lives of people with diabetes. To this end, the IHSG will pursue the following key objectives:
- Identify new and emerging issues and insights about hypoglycaemia from within the scientific community
- Formulate a comprehensive scientific communications platform with which to enhance scientific understanding of the facts and figures of hypoglycaemia, as well as its importance as a barrier to optimal glycaemic control at the practitioner and patient levels
The IHSG will engage in a variety of professional scientific communications endeavours (e.g., publications, symposia, continuing medical education) to achieve these objectives.